Effects of Fas/Fas-ligand interaction on the induction of ACAID.

被引：0
|
作者：
Kawashima, H
Yamagami, S
Gregerson, DS
机构：
[1] JICHI MED SCH,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
[2] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1997年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：912 / 912
页数：1
相关论文
共 50 条
  • [21] A comparative study of Fas and Fas-ligand expression during melanoma progression
    Soubrane, C
    Mouawad, R
    Antoine, EC
    Verola, O
    Gil-Delgado, M
    Khayat, D
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) : 307 - 312
  • [22] Significance of serum Fas-ligand levels in patients with primary biliary cirrhosis and its relationship to histological Fas-ligand expression
    Kisara, N
    Ishii, M
    Ueno, Y
    Igarashi, T
    Mano, Y
    Yahagi, K
    Kobayashi, Y
    Toyota, T
    GASTROENTEROLOGY, 1998, 114 (04) : A1276 - A1276
  • [23] Fas and fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy
    Hammer, A
    Blaschitz, A
    Daxböck, C
    Walcher, W
    Dohr, G
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1999, 41 (01): : 41 - 51
  • [24] The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas
    Gutierrez, LS
    Eliza, M
    Niven-Fairchild, T
    Naftolin, F
    Mor, G
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (03) : 245 - 253
  • [25] Fas-Ligand and immune privilege: The eyes have it
    Ferguson, TA
    Green, DR
    CELL DEATH AND DIFFERENTIATION, 2001, 8 (07): : 771 - 772
  • [26] Modulation of Fas-Ligand/Fas expression in primary mouse hepatocytes by cyclosporin A and tacrolimus
    Dollinger, MM
    Glazyrin, AL
    Howie, SEM
    Harrison, DJ
    JOURNAL OF PATHOLOGY, 1999, 187 : 8A - 8A
  • [27] Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions
    Bajorath, J
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1999, 35 (04) : 475 - 482
  • [28] Fas/Fas-ligand and silent myocardial ischemia in type 2 diabetic patients
    Valensi, P
    Cosson, E
    Pariès, J
    Attali, JR
    Ringuer, AF
    Guillot, R
    Feldmann, G
    DIABETES, 2002, 51 : A164 - A164
  • [29] Fas-Ligand and Immune Privilege: The Eyes Have It
    T A Ferguson
    D R Green
    Cell Death & Differentiation, 2001, 8 : 771 - 772
  • [30] The importance of FAS and FAS-ligand (FAS-L) in the accelerated erythroid apoptosis in Thalassemia Major.
    Schrier, SL
    Centis, F
    Ma, L
    Murra, R
    Angelucci, E
    BLOOD, 2002, 100 (11) : 237A - 237A
12345